Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

BioCorRx Inc. (BICX)

OID · Medical Care Facilities

$0.30+0.05 (+20.00%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$8.7M
P/E (TTM)
EPS
$-0.16
Div Yield
52W Range
$0.20–$1.28
Beta
0.18

Company overview

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss management program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.

Peers in Healthcare

BioCorRx Inc. has no peer companies in this window.

Recent press releases

BioCorRx Inc. has not issued a press release in this window.

SEC filings

All filings →

BioCorRx Inc. has not filed an SEC document in this window.

BioCorRx Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for BioCorRx Inc. in this window.

People at BioCorRx Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$134.9K
NI -$841.4K
06/25
$178.2K
NI -$1.2M
09/25
$635.2K
NI -$1.9M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.11
Prior: $-0.07
Revenue sparkline
BioCorRx Inc. (BICX) Stock Quote, Press Releases,... | Cayman Journal | Cayman Journal